Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495753 · ClinicalTrials.gov registry record · NA
Vaginal Cleansing Before Cesarean Delivery to Reduce Infection
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 608
- Enrollment target
NCT02495753 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 608 participants.
The verdict
NCT02495753, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.
Interventions
- PROCEDURE Vaginal Cleansing
- PROCEDURE Abdominal Cleansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2015-08 |
| Est. Completion | 2021-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02495753
The ClinicalTrials.gov registry entry for NCT02495753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaginal Cleansing is the first listed.
NCT02495753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02495753 about?
NCT02495753 is a clinical study titled "Vaginal Cleansing Before Cesarean Delivery to Reduce Infection". The purpose of this study is to test the hypothesis that vaginal cleansing with povidone-iodine solution immediately prior to cesarean delivery reduces postcesarean infectious morbidity.
What is the current status of trial NCT02495753?
This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2015-08. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02495753?
The interventions under investigation include: Vaginal Cleansing (PROCEDURE), Abdominal Cleansing (PROCEDURE).
Who is sponsoring clinical trial NCT02495753?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.